Telomir Pharmaceuticals TELO Estimates

NASDAQ TELO

$1.12 -0.05 (-4.27%)

At close: Aug 20, 2026 · 4:00 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Revenue Estimates

Quarterly Annual

Metric	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27	Q3 27	Q4 27
Reported (Actual)	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-
High Estimate	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	496,758.28	1.04 M	450,243.82
Low Estimate	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	450,566.72	891,885.46	381,852.18
Consensus Estimate	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	473,662.50	964,985.00	416,048.00

Earnings Per Share (EPS) Estimates

Quarterly Annual

Metric	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27	Q3 27	Q4 27
Reported (Actual)	-0.06	-0.20	-0.07	-0.07	-	-	-	-	-	-	-	-
High Estimate	-	-0.18	-0.08	-0.07	-0.08	-0.08	-0.07	-0.07	-0.07	-0.08	-0.05	-0.06
Low Estimate	-	-0.20	-0.10	-0.07	-0.10	-0.08	-0.09	-0.07	-0.07	-0.08	-0.07	-0.06
Consensus Estimate	-	-0.19	-0.09	-0.07	-0.09	-0.08	-0.08	-0.07	-0.07	-0.08	-0.06	-0.06

Telomir Pharmaceuticals (TELO)

NASDAQ: TELO

$1.12 ▼ -0.05 (-4.27%)

Aug 20, 2026 · 4:00 PM EDT